ARTICLE | Company News
ImmunoGen news
August 2, 1993 7:00 AM UTC
IMGN opened a 31,000 square-foot manufacturing plant in Canton, Mass., for the production of monoclonal antibodies to be used in its Oncolysin portfolio of products for cancer therapy. ...